跳至主要内容
临床试验/NCT02423135
NCT02423135已完成不适用

Detection of Autologous DEHP (DiEthylHexyl Phthalate)-Free Blood Transfusion Using a Combination of Multiple Biomarkers in Different Matrices.

Centre Hospitalier Universitaire Vaudois1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Measurement of blood parameters profile, iron metabolism and genomic compounds

研究概览

简要总结

The aim of the proposed project is to perform a clinical study in which volunteers will receive autologous blood transfusions in DEHP-free blood bags.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Investigator)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •Have to fill the swiss blood donation formulary

排除标准

  • •Cardiovascular disease
  • •Neurologic disease
  • •Not performed a blood donation for 5 weeks ago the start of the study.
  • •Immunological disease

研究组 & 干预措施

Blood bags without DEHP

Experimental

Intervention : Autologous blood transfusion

干预措施: Autologous blood transfusion (Biological)

Blood bags with DEHP

Experimental

Intervention : Autologous blood transfusion

干预措施: Autologous blood transfusion (Biological)

结局指标

主要结局

Measurement of blood parameters profile, iron metabolism and genomic compounds

时间窗: 1 month

Blood profiling such as measurement of concentration of different blood cells and hemoglobin will be measured up to 15 days after blood-reinfusion. Concentration of free-iron, ferritin and hepcidin will be measured in plasma and serum up to 15 days after blood re-infusion. Concentration of circulating microRNAs will be measured in plasma also up to 15 days after blood re-infusion. All measures are compared.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nicolas Leuenberger

Dr, PhD

Centre Hospitalier Universitaire Vaudois

研究点 (1)

Loading locations...

相似试验